Accelerated replicative senescence of the peripheral immune system induced by HIV infection

AIDS

Volumn 14, Issue 7, 2000, Pages 771-780

  Bestilny, Leslie J ^a   Gill, M John ^a   Mody, Christopher H ^a   Riabowol, Karl T ^a  

^a Health Sciences Centre Calgary   (Canada)

Author keywords

CD4; CD8; Natural history; Telomerase; Telomeres

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TELOMERASE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; ASSAY; CELL AGING; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE;

AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MIDDLE AGED; TELOMERASE; TELOMERE;

EID: 0034107028     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200005050-00002     Document Type: Article

References (47)

1. 1. Meyne J, Ratliff JL, Moyzis RK. Conservation of the human telomere sequence (TTAGGG) n among vertebrates. Proc Natl Acad Sci USA 1989, 86:7049-7053.
2. 2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
3. 3. Allsopp RC, Vaziri H, Patterson C et al. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1989, 89:10114-10118.
4. 4. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91:9857-9860.
5. 5. Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol. Today 1997, 18:450-454.
6. 6. Weng N-P, Levine BL, Hodes CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995, 92:11091-11094.
7. 7. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
8. 8. Margolick JB, Donnenberg AD, Munoz A et al. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. J. Acquir Immune Defic Syndr 1993, 6:153-161.
9. 9. Adelman LM, Wofsy D. T-cell homeostasis: implications in HIV infection. J. Acquir Immune Defic Syndr 1993, 6:144-152.
10. 10. Zaunders J, Carr A, McNally L, Penny R , Cooper DA. Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes. AIDS 1995, 9:561-566.
11. 11. Coffin JM. HIV population dynamics in vivo: implications for genetics variation, pathogenesis, and therapy. Science 1995, 267:483-489.
12. 12. Caruso A, Licenziati S, Canaris AD. T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens. J. Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:61-69.
13. 13. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
14. 14. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
15. 15. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998, 279:1223-1227.
16. 16. Effros RB, Allsopp R, Chie C et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10:F17-F22.
17. 17. Phillips AN, Lee CA, Elford J et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr 1991, 4:970-975.
18. 18. Ferro S, Salit E. HIV infection in patients over 55 years of age. J. Acquir Immune Defic Syndr 1992, 5:348-353.
19. 19. Operskalski EA, Stram DO, Lee H et al. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. J. Infect Dis 1995, 172:648-655.
20. 20. Wolthers KC, Bea G, Wisman A et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 1996, 274:1543-1547.
21. 21. Palmer LD, Weng N, Levine BL, June CH, Lane HC, Hodes, RJ. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins J Exp Med 1997, 185: 1381-1386.
22. 22. Pommier J, Gauthier L, Livartowski J et al. Immunosenescence in HIV pathogenesis. Virology 1997, 231:148-154.
23. 23. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual, second edition. Cold Spring Harbour, NY: Cold Spring Laboratory; 1989, 9.16-9.19.
24. 24. Box GEP, Cox DR. An analysis of transformations (with discussion). J Statist Soc [B] 1964, 26:211-252.
25. 25. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990, 346:866-868.
26. 26. Vaziri H, Schachter F, Uchida L et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphoblasts. Am J Hum Genet 1993, 52:661-667.
27. 27. Finkel TH, Tudor-Williams G, Banda NK et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med 1995, 1:129-134.
28. 28. Li CJ, Freidman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268:429-431.
29. 29. Westendorp MO, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and Gp120. Nature 1995, 375:497-500.
30. 30. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993, 14:131-140.
31. 31. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995, 85:2315-2320.
32. 32. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92:9082-9086.
33. 33. Hiyama K, Mirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155:3711-3715.
34. 34. Pisciotta AV, Westring DW, DePrey C, Walsh B. Mitogenic effect of phytohaemagglutinin at different ages. Nature 1967, 215:193-194.
35. 35. Perillo NL, Naeim F, Walford RL, Effros RB. In vitro cellular aging in T-lymphocyte cultres; analysis of DNA content and cell size. Exp Cell Res 1993, 207:131-135.
36. 36. Miller RA. The aging immune system: primer and prospectus. Science 1996, 273:70-74.
37. 37. Mahalingam M, Pozniak A, McManus TJ, Vergani D, Peakman M. Abnormalities of CD45 isoform expression in HIV infection. Clin Immunol Immunopathol 1996, 81:210-214.
38. 38. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990, 87:6058-6062.
39. 39. Van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, van Lier RA, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin. Invest. 1990, 86:293-299.
40. 40. Sachsenberg N, Perelson AS, Yerly S et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 1998, 187:1295-1303.
41. 41. Macreadie JG, Castelli LA, Hewish DR, Kirkpatrick A, Ward AC, Azad AA. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc Natl Acad Sci USA 1995, 92:2770-2774.
42. 42. He J Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in theG2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995, 69:6705-6711.
43. 43. Bartz SR, Rogel ME, Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 1996, 70:2324.
44. 44. Ayyavoo V, Mahalingam S, Rafaeli Y et al. HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J Leuk Biol 1997, 62:93-99.
45. 45. Conners M, Kovacs JA, Krevat S et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997, 3: 533-540.
46. 46. Kaushal S, La Russa VF, Gartner S et al. Exposure of human CD34+ cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitro. Blood 1996, 88:130.
47. 47. Tenner-Racz K, Stellbrink HJ, van Lunzen J. The unenlarged lymph nodes of HIV-1 -infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Exp Med 1998, 187:949-959.